By Sheryl Gay Stolberg
Published Sept. 2, 2021
Updated Sept. 8, 2021
The White House, under pressure to do more to address the global coronavirus pandemic, said Thursday that it will invest $2.7 billion to ramp up domestic production of critical vaccine components as part of President Biden’s push to make the United States the “arsenal of vaccines for the world.”
The money will go to firms doing business in the United States that make supplies necessary for vaccine production, including lipids, bioreactor bags, tubing, needles and syringes, officials said. It will come from funds appropriated by Congress through the American Rescue Plan, the $1.9 trillion economic stimulus package Mr. Biden signed into law in March.